Bioshares recommendation + valuation interesting. Market neutral.
Positive releases = small transient SP rises, if any. Holding .14-.16.
Market spooked after 730? Other sector players pulling interest? Financials?
With 0.26 SPP Q3-14 subscriber run, curious about upcoming CEO NY ARMID pitch.